Literature DB >> 20171521

Radiation dose-volume effects in the lung.

Lawrence B Marks1, Soren M Bentzen, Joseph O Deasy, Feng-Ming Spring Kong, Jeffrey D Bradley, Ivan S Vogelius, Issam El Naqa, Jessica L Hubbs, Joos V Lebesque, Robert D Timmerman, Mary K Martel, Andrew Jackson.   

Abstract

The three-dimensional dose, volume, and outcome data for lung are reviewed in detail. The rate of symptomatic pneumonitis is related to many dosimetric parameters, and there are no evident threshold "tolerance dose-volume" levels. There are strong volume and fractionation effects. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20171521      PMCID： PMC3576042          DOI： 10.1016/j.ijrobp.2009.06.091

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


  67 in total

1.  Total thoracic irradiation combined with intravenous injection of autogenous marrow.

Authors:  K A NEWTON
Journal:  Clin Radiol       Date:  1960-01       Impact factor: 2.350

2.  Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer?

Authors:  Keith L Miller; Timothy D Shafman; Mitchell S Anscher; Su-Min Zhou; Robert W Clough; Jennifer L Garst; Jeffrey Crawford; Julian Rosenman; Mark A Socinski; William Blackstock; Gregory S Sibley; Lawrence B Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-01-01       Impact factor: 7.038

Review 3.  The linear-quadratic transformation of dose-volume histograms in fractionated radiotherapy.

Authors:  T E Wheldon; C Deehan; E G Wheldon; A Barrett
Journal:  Radiother Oncol       Date:  1998-03       Impact factor: 6.280

4.  Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.

Authors:  Benjamin Movsas; Charles Scott; Corey Langer; Maria Werner-Wasik; Nicos Nicolaou; Ritsuko Komaki; Mitchell Machtay; Colum Smith; Rita Axelrod; Linda Sarna; Todd Wasserman; Roger Byhardt
Journal:  J Clin Oncol       Date:  2005-04-01       Impact factor: 44.544

5.  Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.

Authors:  T Piotrowski; M Matecka-Nowak; P Milecki
Journal:  Neoplasma       Date:  2005       Impact factor: 2.575

Review 6.  Quantitative clinical radiobiology of early and late lung reactions.

Authors:  S M Bentzen; J Z Skoczylas; J Bernier
Journal:  Int J Radiat Biol       Date:  2000-04       Impact factor: 2.694

7.  Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)

Authors:  M V Graham; J A Purdy; B Emami; W Harms; W Bosch; M A Lockett; C A Perez
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-09-01       Impact factor: 7.038

8.  Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.

Authors:  Tae Hyun Kim; Kwan Ho Cho; Hong Ryull Pyo; Jin Soo Lee; Jae Ill Zo; Dae Ho Lee; Jong Mog Lee; Hyae Young Kim; Bin Hwangbo; Sung Yong Park; Joo Young Kim; Kyung Hwan Shin; Dae Yong Kim
Journal:  Radiology       Date:  2005-02-09       Impact factor: 11.105

9.  Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients.

Authors:  S L Kwa; J V Lebesque; J C Theuws; L B Marks; M T Munley; G Bentel; D Oetzel; U Spahn; M V Graham; R E Drzymala; J A Purdy; A S Lichter; M K Martel; R K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-08-01       Impact factor: 7.038

10.  Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis.

Authors:  S L Kwa; J C Theuws; A Wagenaar; E M Damen; L J Boersma; P Baas; S H Muller; J V Lebesque
Journal:  Radiother Oncol       Date:  1998-07       Impact factor: 6.280
View more
  311 in total

1.  Predicting toxicity from radiation therapy--it's genetic, right?

Authors:  Chris R Kelsey; Barry S Rosenstein; Lawrence B Marks
Journal:  Cancer       Date:  2011-12-05       Impact factor: 6.860

Review 2.  Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer.

Authors:  Joshua D Palmer; Nicholas G Zaorsky; Matthew Witek; Bo Lu
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

Review 3.  Intensity-Modulated Radiotherapy versus 3-Dimensional Conformal Radiotherapy Strategies for Locally Advanced Non-Small-Cell Lung Cancer.

Authors:  Uğur Selek; Yasemin Bölükbaşı; James W Welsh; Erkan Topkan
Journal:  Balkan Med J       Date:  2014-09-13       Impact factor: 2.021

4.  Density overwrites of internal tumor volumes in intensity modulated proton therapy plans for mobile lung tumors.

Authors:  Pablo Botas; Clemens Grassberger; Gregory Sharp; Harald Paganetti
Journal:  Phys Med Biol       Date:  2018-01-30       Impact factor: 3.609

5.  New approach in lung cancer radiotherapy offers better normal tissue sparing.

Authors:  Ivaylo B Mihaylov
Journal:  Radiother Oncol       Date:  2016-09-28       Impact factor: 6.280

6.  Lipopolysaccharide-binding protein is efficient in biodosimetry during radiotherapy of lung cancer.

Authors:  Justyna Chalubinska-Fendler; Wojciech Fendler; Michal Spych; Krystyna Wyka; Jolanta Luniewska-Bury; Jacek Fijuth
Journal:  Biomed Rep       Date:  2016-08-08

Review 7.  Radiation-related treatment effects across the age spectrum: differences and similarities or what the old and young can learn from each other.

Authors:  Matthew J Krasin; Louis S Constine; Debra L Friedman; Lawrence B Marks
Journal:  Semin Radiat Oncol       Date:  2010-01       Impact factor: 5.934

8.  Interim Analysis of a Two-Institution, Prospective Clinical Trial of 4DCT-Ventilation-based Functional Avoidance Radiation Therapy.

Authors:  Yevgeniy Vinogradskiy; Chad G Rusthoven; Leah Schubert; Bernard Jones; Austin Faught; Richard Castillo; Edward Castillo; Laurie E Gaspar; Jennifer Kwak; Timothy Waxweiler; Michele Dougherty; Dexiang Gao; Craig Stevens; Moyed Miften; Brian Kavanagh; Thomas Guerrero; Inga Grills
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-10-18       Impact factor: 7.038

9.  Hybrid volumetric modulated arc therapy for whole breast irradiation: a dosimetric comparison of different arc designs.

Authors:  Velayudham Ramasubramanian; Karunakaran Balaji; Sitaraman Balaji Subramanian; Krishnamoorthi Sathiya; Moorthi Thirunavukarasu; Chandrasekaran Anu Radha
Journal:  Radiol Med       Date:  2019-01-30       Impact factor: 3.469

10.  Stereotactic body radiotherapy for pulmonary metastases. Prognostic factors and adverse respiratory events.

Authors:  T Inoue; R-J Oh; H Shiomi; N Masai; H Miura
Journal:  Strahlenther Onkol       Date:  2013-02-20       Impact factor: 3.621
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.